CompletedPhase 4

Study Of Airway Physiology In Adults. SERETIDE DISKUS® Inhaler and FLIXOTIDE® Inhaler Are Trademarks of GSK Croup of Companies.

United Kingdom48 participantsStarted 2002-12

Plain-language summary

Comparison of two asthma treatments by lung function measures.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion: * Physician documented diagnosis of asthma which has been present for at least 6 months. * Receiving a total daily dose of 200-500mcg/day beclomethasone dipropionate or equivalent for at least 4 weeks prior to the start of the run-in period. Exclusion: * Has had 3 or more courses of oral corticosteroids in the 12 months previous to visit 1

What they're measuring

Specific airway resistance (sRAW kPa.L.s) measured before the study medication dose at the end of treatment (week 4)

Trial details

NCT IDNCT00370591

SponsorGlaxoSmithKline

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2004-04

View on ClinicalTrials.gov More Asthma trials